Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer.
Pietrantonio F, Oddo D, Gloghini A, Valtorta E, Berenato R, Barault L, Caporale M, Busico A, Morano F, Gualeni AV, Alessi A, Siravegna G, Perrone F, Di Bartolomeo M, Bardelli A, de Braud F, Di Nicolantonio F. Pietrantonio F, et al. Among authors: busico a. Cancer Discov. 2016 Sep;6(9):963-71. doi: 10.1158/2159-8290.CD-16-0297. Epub 2016 Jun 20. Cancer Discov. 2016. PMID: 27325282
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation.
Pietrantonio F, Perrone F, de Braud F, Castano A, Maggi C, Bossi I, Gevorgyan A, Biondani P, Pacifici M, Busico A, Gariboldi M, Festinese F, Tamborini E, Di Bartolomeo M. Pietrantonio F, et al. Among authors: busico a. Ann Oncol. 2014 Feb;25(2):404-8. doi: 10.1093/annonc/mdt547. Epub 2013 Dec 29. Ann Oncol. 2014. PMID: 24379162 Free article. Clinical Trial.
Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.
Pelosi G, Fabbri A, Papotti M, Rossi G, Cavazza A, Righi L, Tamborini E, Perrone F, Settanni G, Busico A, Testi MA, Maisonneuve P, De Braud F, Garassino M, Valeri B, Sonzogni A, Pastorino U. Pelosi G, et al. Among authors: busico a. J Thorac Oncol. 2015 Nov;10(11):1560-9. doi: 10.1097/JTO.0000000000000658. J Thorac Oncol. 2015. PMID: 26317919 Free article.
Challenging Lung Carcinoma with Coexistent ΔNp63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells.
Pelosi G, Fabbri A, Tamborini E, Perrone F, Testi AM, Settanni G, Busico A, Centonze G, Braidotti P, Bulfamante G, De Braud F, Garassino M, Pastorino U. Pelosi G, et al. Among authors: busico a. J Thorac Oncol. 2015 Oct;10(10):1500-2. doi: 10.1097/JTO.0000000000000553. J Thorac Oncol. 2015. PMID: 26398824 Free article. No abstract available.
Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sections.
Pelosi G, Perrone F, Tamborini E, Fabbri A, Testi MA, Busico A, Settanni G, Picciani B, Bovio E, Sonzogni A, Valeri B, Garassino M, De Braud F, Pastorino U. Pelosi G, et al. Among authors: busico a. Virchows Arch. 2016 Apr;468(4):451-61. doi: 10.1007/s00428-016-1906-0. Epub 2016 Jan 27. Virchows Arch. 2016. PMID: 26818831
Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules.
Pelosi G, Pellegrinelli A, Fabbri A, Tamborini E, Perrone F, Settanni G, Busico A, Picciani B, Testi MA, Militti L, Maisonneuve P, Valeri B, Sonzogni A, Proto C, Garassino M, De Braud F, Pastorino U. Pelosi G, et al. Among authors: busico a. Virchows Arch. 2016 Jun;468(6):651-62. doi: 10.1007/s00428-016-1931-z. Epub 2016 Apr 7. Virchows Arch. 2016. PMID: 27056568
AKT1 and BRAF mutations in pediatric aggressive fibromatosis.
Meazza C, Belfiore A, Busico A, Settanni G, Paielli N, Cesana L, Ferrari A, Chiaravalli S, Massimino M, Gronchi A, Colombo C, Pilotti S, Perrone F. Meazza C, et al. Among authors: busico a. Cancer Med. 2016 Jun;5(6):1204-13. doi: 10.1002/cam4.669. Epub 2016 Apr 8. Cancer Med. 2016. PMID: 27062580 Free PMC article.
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.
Pietrantonio F, Berenato R, Maggi C, Caporale M, Milione M, Perrone F, Tamborini E, Baratti D, Kusamura S, Mariani L, Niger M, Mennitto A, Gloghini A, Bossi I, Settanni G, Busico A, Bagnoli PF, Di Bartolomeo M, Deraco M, de Braud F. Pietrantonio F, et al. Among authors: busico a. J Transl Med. 2016 May 6;14(1):125. doi: 10.1186/s12967-016-0877-x. J Transl Med. 2016. PMID: 27154293 Free PMC article. Clinical Trial.
Toward the molecular dissection of peritoneal pseudomyxoma.
Pietrantonio F, Perrone F, Mennitto A, Gleeson EM, Milione M, Tamborini E, Busico A, Settanni G, Berenato R, Caporale M, Morano F, Bossi I, Pellegrinelli A, Di Bartolomeo M, de Braud F, Baratti D, Bowne WB, Kusamura S, Deraco M. Pietrantonio F, et al. Among authors: busico a. Ann Oncol. 2016 Nov;27(11):2097-2103. doi: 10.1093/annonc/mdw314. Epub 2016 Aug 8. Ann Oncol. 2016. PMID: 27502722 Free article.
56 results